New Business and Funding Models To Accelerate the Development of Life-Preserving Therapies

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
In this presentation, Anthos Therapeutics & Lonza Pharma & Biotech will explore how innovative business models and strong partnerships can help accelerate the clinical development process to bring vital, but underfunded, drugs to patients. The partners will discuss how their program across the development and manufacturing of MAA868, an antibody directed at Factor XI and Xia, is designed to deliver quality with agility, speed and an investor focus.

Speaker - Jonathan Freeman, PhD, Founder & COO, Anthos Therapeutics, Senior Advisor Blackstone Life Sciences & Abdelaziz Toumi, PhD, Head of Ibex™ Design & Develop Customer Solutions, Lonza Pharma & Biotech
Sponsored By